Seelos Therapeutics, Inc.
SEEL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $865,575 | $9,242,411 | $18,963,298 | $9,053,603 |
| - Cash | $2,996 | $15,533 | $78,734 | $15,662 |
| + Debt | $14,228 | $20,122 | $18,958 | $9,724 |
| Enterprise Value | $876,807 | $9,247,000 | $18,903,522 | $9,047,665 |
| Revenue | $2,203 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$27,914 | -$53 | $0 | $0 |
| % Margin | -1,267.1% | – | – | – |
| EBITDA | -$37,750 | -$73,467 | $0 | $0 |
| % Margin | -1,713.6% | – | – | – |
| Net Income | -$37,882 | -$76,138 | -$67,533 | -$19,220 |
| % Margin | -1,719.6% | – | – | – |
| EPS Diluted | -7.73 | -21.48 | -22.29 | -12.88 |
| % Growth | 64% | 3.6% | -73.1% | – |
| Operating Cash Flow | -$23,912 | -$61,604 | -$48,995 | -$20,913 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$23,912 | -$61,604 | -$48,995 | -$20,913 |